enGene Named a BioSpace 2026 Best Places to Work Winner

BOSTON & MONTREAL, November 04, 2025--enGene Holdings Inc. ("enGene" or the "Company") (Nasdaq: ENGN), a clinical-stage, ...

'I've had 35 operations and was told I should be dead'

Meet Emma Sheppard, a 42-year-old woman who has undergone surgery 35 times in the past 28 years, with her first operation ...

Woman once told she 'should be dead' has had 35 operations

Meet the woman who has had surgery 35 times in 28 years - first going under the knife when she was just 14. Emma Sheppard, 42 ...

Woman who's had 35 surgeries was once told she 'should be dead'

Meet the woman who has had surgery 35 times in 28 years - first going under the knife when she was just 14. Emma Sheppard, 42 ...
Cancer Therapy Advisor

ESMO 2025: Novel Combinations Are Changing Standards of Care in Bladder Cancer

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.
Healio

Adding durvalumab to BCG extends DFS for high-risk bladder cancer; toxicities a concern

The addition of durvalumab to bacillus Calmette-Guérin therapy significantly extended DFS for patients with high-risk non-muscle-invasive bladder cancer, according to results of a randomized phase 3 ...